Stockpolly
Search
ORMP · NASDAQ · Biotechnology

Oramed Pharmaceuticals (ORMP)

Develops oral formulations for insulin and other therapeutic proteins.

$4.85
Pre-market−0.22 (−4.34%)
At close$5.07(+4.54%)
Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions64 holders · as of Mar 31, 202631.83%13.24M shares
Insiders9 holders · as of Jul 2, 202617.62%7.33M shares
Otherremainder50.55%21.03M shares

41.60M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Nadav Kidron1Insiderdirector, officer: President and CEO
9.15%3.12M13Dfiled Mar 31, 2026 ↗
BML Capital Management, LLCInstitution
7.61%3.17M13Fas of Mar 31, 2026
Aquamarine Financial (Cayman) LtdInstitution
5.08%2.11M13Fas of Mar 31, 2026
BML Investment Partners, L.P.Institution
4.92%2.05M13Gfiled Sep 16, 2024 ↗
Mercer Global Advisors Inc /AdvInstitution
4.59%1.91M13Fas of Mar 31, 2026
Gem Investment Advisors, LLCInstitution
3.94%1.64M13Fas of Mar 31, 2026
Murchinson Ltd.Institution
3.16%1.32M13Fas of Mar 31, 2026
Miriam KidronInsiderdirector, officer: Chief Scientific Officer
2.72%1.13MForm 4filed Mar 31, 2026 ↗
Joshua HexterInsiderofficer: COO & CBO
2.58%1.07MForm 4filed Jul 2, 2026 ↗
Avraham GabayInsiderofficer: Chief Financial Officer
1.61%671,785Form 4filed Jul 2, 2026 ↗
Boothbay Fund Management, LLCInstitution
1.44%600,71613Fas of Mar 31, 2026
Marshall Wace, LLPInstitution
0.62%259,61113Fas of Mar 31, 2026
Rathbones Group PLCInstitution
0.56%233,01813Fas of Mar 31, 2026
Arie MayerInsiderdirector
0.40%168,009Form 4filed Jan 5, 2026 ↗
Dimensional Fund Advisors LPInstitution
0.38%158,20913Fas of Mar 31, 2026
Wells Fargo & Company/MNInstitution
0.38%157,58613Fas of Mar 31, 2026
Ritholtz Wealth ManagementInstitution
0.37%155,47913Fas of Mar 31, 2026
Renaissance Technologies LLCInstitution
0.36%147,70013Fas of Mar 31, 2026
Bank of America Corp /DE/Institution
0.35%146,15213Fas of Mar 31, 2026
Susquehanna International Group, LLPInstitution
0.33%136,21813Fas of Mar 31, 2026
Leonard SankInsiderdirector
0.32%134,531Form 4filed Jun 9, 2025 ↗
Benjamin ShapiroInsiderdirector
0.30%123,220Form 4filed Jan 5, 2026 ↗
O'Shaughnessy Asset Management, LLCInstitution
0.28%116,36313Fas of Mar 31, 2026
Daniel AghionInsiderdirector
0.27%113,441Form 4filed Jan 2, 2026 ↗
Yehuda ReznickInsiderdirector
0.25%105,180Form 4filed Jan 5, 2026 ↗
  1. Nadav Kidron's transaction reports restate only vehicles that traded; the 2025 ownership statement (3.12M) plus the 690.8K net shares acquired since is used instead.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

64 holders · 13.24M shares · 16 new positions · 35 increased · 16 reduced · 9 closed

HolderShares% outstandingChg q/qFiled
BML Capital Management, LLC3.17M7.61%0May 6, 2026
Aquamarine Financial (Cayman) Ltd2.11M5.08%+139.3KMay 15, 2026
Mercer Global Advisors Inc /Adv1.91M4.59%+1.91MnewMay 15, 2026
Gem Investment Advisors, LLC1.64M3.94%−358.7KMay 15, 2026
Murchinson Ltd.1.32M3.16%−25.0KMay 15, 2026
Boothbay Fund Management, LLC600.7K1.44%−11.4KMay 15, 2026
Marshall Wace, LLP259.6K0.62%+556May 15, 2026
Rathbones Group PLC233.0K0.56%0Jun 9, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Nadav Kidron7.60%3.12M13DAug 28, 2025 ↗
Aquamarine Financial (Cayman) Ltd5.06%2.05M13GMay 15, 2026 ↗
BML Investment Partners, L.P.5.00%2.05M13GSep 16, 2024 ↗

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Jul 1, 2026
Avraham Gabayofficer: Chief Financial Officer
Sale73,360$4.51671,785
Jul 1, 2026
Joshua Hexterofficer: COO & CBO
Sale137,000$4.461,023,384

CongressHouse and Senate disclosures

Not reported.